STOCK TITAN
  1. Home
  2. News
  3. SRTS

Sensus Healthcare Inc - SRTS STOCK NEWS

Welcome to our dedicated news page for Sensus Healthcare (Ticker: SRTS), a resource for investors and traders seeking the latest updates and insights on Sensus Healthcare.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sensus Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sensus Healthcare's position in the market.

News
Sensus Healthcare Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces financial results for the three and nine months ended September 30, 2023, reflecting lower revenues due to seasonality and macroeconomic conditions. The company reported revenues of $3.9 million, net loss of $1.5 million, and $20.5 million in cash and cash equivalents. The financial results were impacted by lower superficial radiotherapy (SRT) unit sales and lower sales to a large customer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.41%
Tags
earnings
-
News
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
Rhea-AI Summary
Sensus Healthcare, Inc. (Nasdaq: SRTS) will hold a conference call on November 9, 2023, at 4:30 p.m. Eastern time to discuss the financial results for Q3 2023. The call will include a business update and discussion on recent and upcoming milestones. Participants can pre-register for the call to receive a unique dial-in number. The call will be webcast live and a telephone replay will be available until December 9th.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
conferences earnings
-
News
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
Rhea-AI Summary
Sensus Healthcare to present at Roth MKM 2023 Healthcare Opportunities Conference and participate in Fall Clinical Dermatology Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
News
Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
Rhea-AI Summary
Sensus Healthcare announces the shipment of an SRT-100+ System to Cape Cod Hospital, marking their ongoing success in the U.S. Northeast region. More hospitals are inquiring about SRT as a non-invasive skin cancer treatment option. Sensus will be demonstrating its products at the ASTRO Annual Meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
-
News
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
Rhea-AI Summary
Sensus Healthcare to showcase its SRT devices at ASTRO Annual Meeting, presenting advancements in superficial radiotherapy for non-melanoma skin cancer and keloids. The devices offer a non-surgical, painless, and cosmetically appealing treatment option. Sensus Healthcare aims to enhance patient care within radiation oncology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
-
News
Sensus Healthcare Announces New $3 Million Share Repurchase Program
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.33%
Tags
buyback
News
Sensus Healthcare Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Sensus Healthcare announces Q2 2023 financial results with revenues of $4.5 million, a 33% increase from Q1 2023. Net loss for Q2 2023 was $0.4 million, compared to net income of $3.5 million in Q2 2022. Expects to ship at least 60 SRT units during 2023 and return to profitability in H2 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.97%
Tags
earnings
-
News
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
conferences earnings
-
News
Sensus Healthcare Completes Installation of its First SRT System in Ireland
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
News
Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.8%
Tags
partnership
Stock SRTS logo
Sensus Healthcare Inc

Nasdaq:SRTS

SRTS Rankings

#4652 Ranked by Market Cap
#5389 Ranked by Stock Gains
N/A Ranked by Dividends

SRTS Stock Data

55.41M
13.07M
21.39%
17.05%
0.2%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Boca Raton

About SRTS

sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.